BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND TERT, EST2, Q8NG46, Q8N6C3, Q2XS35, O14783, O14746, 7015, hEST2, TCS1, TRT, TP2 AND Diagnosis
31 results:

  • 1. Accelerator-Based Production of Scandium Radioisotopes for Applications in prostate cancer: Toward Building a Pipeline for Rapid Development of Novel Theranostics.
    Meier JP; Zhang HJ; Freifelder R; Bhuiyan M; Selman P; Mendez M; Kankanamalage PHA; Brossard T; Pusateri A; Tsai HM; Leoni L; Penano S; Ghosh K; Broder BA; Markiewicz E; Renne A; Stadler W; Weichselbaum R; Nolen J; Kao CM; Chitneni SK; Rotsch DA; Szmulewitz RZ; Chen CT
    Molecules; 2023 Aug; 28(16):. PubMed ID: 37630292
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Current Management and Controversies Surrounding Andropause.
    Mian AH; Yang DY; Kohler TS
    Urol Clin North Am; 2022 Nov; 49(4):583-592. PubMed ID: 36309415
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The role of testosterone in men's health: is it time for a new approach?
    Diokno AC
    Int Urol Nephrol; 2022 Nov; 54(11):2767-2774. PubMed ID: 35909146
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Post-market safety and efficacy profile of subcutaneous testosterone enanthate-autoinjector: a cohort analysis.
    Choi EJ; Xu P; El-Khatib FM; Kavoussi PK; Yafi FA
    Int J Impot Res; 2022 Aug; 34(5):467-470. PubMed ID: 34007063
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Two-stage Study of Familial prostate cancer by Whole-exome Sequencing and Custom Capture Identifies 10 Novel Genes Associated with the Risk of prostate cancer.
    Schaid DJ; McDonnell SK; FitzGerald LM; DeRycke L; Fogarty Z; Giles GG; MacInnis RJ; Southey MC; Nguyen-Dumont T; Cancel-Tassin G; Cussenot O; Whittemore AS; Sieh W; Ioannidis NM; Hsieh CL; Stanford JL; Schleutker J; Cropp CD; Carpten J; Hoegel J; Eeles R; Kote-Jarai Z; Ackerman MJ; Klein CJ; Mandal D; Cooney KA; Bailey-Wilson JE; Helfand B; Catalona WJ; Wiklund F; Riska S; Bahetti S; Larson MC; Cannon Albright L; Teerlink C; Xu J; Isaacs W; Ostrander EA; Thibodeau SN
    Eur Urol; 2021 Mar; 79(3):353-361. PubMed ID: 32800727
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Integrated immunohistochemical and molecular analysis improves diagnosis of high-grade carcinoma in the urinary bladder of patients with prior radiation therapy for prostate cancer.
    Chan E; Garg K; Stohr BA
    Mod Pathol; 2020 Sep; 33(9):1802-1810. PubMed ID: 32313185
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. European Academy of Andrology (EAA) guidelines on investigation, treatment and monitoring of functional hypogonadism in males: Endorsing organization: European Society of Endocrinology.
    Corona G; Goulis DG; Huhtaniemi I; Zitzmann M; Toppari J; Forti G; Vanderschueren D; Wu FC
    Andrology; 2020 Sep; 8(5):970-987. PubMed ID: 32026626
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. tert- beyond the territory: Usage of PCR-based tert promoter assay in defining urothelial carcinoma in a case of long-standing prostatic adenocarcinoma.
    Mannan R; Taylor AS; Spratt DE; Chinnaiyan AM; Montgomery JS; Brown NA; Mehra R
    Pathol Res Pract; 2020 Jan; 216(1):152663. PubMed ID: 31630874
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. High-grade Adenocarcinoma of the prostate Mimicking Urothelial Carcinoma is Negative for tert Mutations.
    Alaghehbandan R; Vanecek T; Trpkov K; Comperat E; Kristiansen G; Svajdler M; Cempirkova D; Pavlovsky M; Pivovarcikova K; Stehlikova A; Hora M; Michal M; Hes O
    Appl Immunohistochem Mol Morphol; 2019 Aug; 27(7):523-528. PubMed ID: 31393284
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Testosterone replacement therapy is associated with an increased risk of urolithiasis.
    McClintock TR; Valovska MI; Kwon NK; Cole AP; Jiang W; Kathrins MN; Bhojani N; Haleblian GE; Koehlmoos T; Haider AH; Basaria S; Trinh QD
    World J Urol; 2019 Dec; 37(12):2737-2746. PubMed ID: 30903351
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Effect of testosterone replacement therapy on sexual function and glycemic control among hypogonadal men with type 2 diabetes mellitus.
    Shigehara K; Konaka H; Kato Y; Iijima M; Nakashima K; Kawaguchi S; Nohara T; Izumi K; Namiki M; Mizokami A
    Int J Impot Res; 2019 Jan; 31(1):25-30. PubMed ID: 30135606
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Clinical significance of PSMA, tert and PDEF in malignant tumors of the prostate.
    Situ J; Zhang H; Lu L; Li K; Hu C; Wang DJ
    Eur Rev Med Pharmacol Sci; 2017 Aug; 21(15):3347-3352. PubMed ID: 28829509
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Risk of cancer in patients with genital warts: A nationwide, population-based cohort study in Taiwan.
    Cho CY; Lo YC; Hung MC; Lai CC; Chen CJ; Wu KG
    PLoS One; 2017; 12(8):e0183183. PubMed ID: 28806741
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. EMAS position statement: Testosterone replacement therapy in the aging male‏.
    Dimopoulou C; Ceausu I; Depypere H; Lambrinoudaki I; Mueck A; Pérez-López FR; Rees M; van der Schouw YT; Senturk LM; Simonsini T; Stevenson JC; Stute P; Goulis DG
    Maturitas; 2016 Feb; 84():94-9. PubMed ID: 26614257
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Testosterone Replacement Therapy and Mortality in Older Men.
    Hackett GI
    Drug Saf; 2016 Feb; 39(2):117-30. PubMed ID: 26482385
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Ethnicity and prostate cancer: the way to solve the screening problem?
    Bokhorst LP; Roobol MJ
    BMC Med; 2015 Aug; 13():179. PubMed ID: 26239718
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Telomerase reverse transcriptase promoter mutations in glandular lesions of the urinary bladder.
    Vail E; Zheng X; Zhou M; Yang X; Fallon JT; Epstein JI; Zhong M
    Ann Diagn Pathol; 2015 Oct; 19(5):301-5. PubMed ID: 26239299
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [Markers for non-invasive molecular genetic diagnosis of oncourological diseases].
    Mikhaĭlenko DS; Perepechin DV; Apolikhin OI; Efremov GD; Sivkov AV
    Urologiia; 2014; (5):116-20. PubMed ID: 25807773
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Association of genetic polymorphisms in the telomerase reverse transcriptase gene with prostate cancer aggressiveness.
    Wu D; Yu H; Sun J; Qi J; Liu Q; Li R; Zheng SL; Xu J; Kang J
    Mol Med Rep; 2015 Jul; 12(1):489-97. PubMed ID: 25738283
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Testosterone replacement therapy in men with prostate cancer: a time-varying analysis.
    Kaplan AL; Lenis AT; Shah A; Rajfer J; Hu JC
    J Sex Med; 2015 Feb; 12(2):374-80. PubMed ID: 25496237
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.